Review Details Distinct Heart Disease Trajectories in Women Across Diabetes Types
A narrative review shows that type 1 and type 2 diabetes distinctly blunt female cardioprotection against coronary artery disease through ...
A narrative review shows that type 1 and type 2 diabetes distinctly blunt female cardioprotection against coronary artery disease through ...
In ambulatory heart failure, lower serum chloride levels are associated with poor outcomes independently of sodium, while the clinical benefits ...
A study of 1,069 older Turkish adults found SGLT2 inhibitor use was not associated with recurrent falls, while antidepressants and ...
A systematic review of real-world cohorts found lower pooled estimates for pneumonia and sepsis with SGLT2 inhibitors versus DPP-4 inhibitors ...
A German health insurance model projects that early empagliflozin after heart attack yields modest quality-adjusted survival gains at an incremental ...
A new review proposes the MMCK syndrome, an operational extension of the CKM framework that integrates MASLD liver fibrosis scoring ...
A new review finds that combining SGLT2 inhibitors with GLP-1 receptor agonists in heart failure is mechanistically plausible and generally ...
A retrospective study of 1925 Japanese patients with type 2 diabetes found biguanides lowered HbA1c more than SGLT2 inhibitors, while ...
A scoping review of 65 sources finds that PPIs, SGLT2 inhibitors, diuretics and metformin act on magnesium and other micronutrients ...
An analysis of Scottish and Welsh healthcare databases found seven potential prescribing cascades in which new drugs were started to ...
A GeroScience commentary argues that veterinary conditional approval frameworks and existing mortality-benefiting drugs could guide human lifespan therapeutics development.
A new narrative review argues that GLP-1 receptor agonists should be repositioned as foundational cardio-renal-metabolic protectors, with trial evidence extending ...
A mini review used Swiss Target Prediction to map the probable protein targets of seven major classes of antidiabetic drugs ...
A new review argues that heart failure with preserved ejection fraction in diabetes may represent a cardiac manifestation of diabetic ...
A new review finds cardiovascular disease remains a major cause of morbidity and mortality in type 1 diabetes, with dedicated ...
A new narrative review argues that chronic inflammation, gut microbiota dysbiosis, and mitochondrial dysfunction are reshaping type 2 diabetes care ...
A study of 1,061 endocrinologists found that higher scores on ABIM's Longitudinal Knowledge Assessment were associated with a larger increase ...
A retrospective propensity-matched study of 120 hemodynamically stable patients found that chronic SGLT2 inhibitor use was associated with better right ...
A controlled rat study found that simulated 6,000-meter hypoxia raised dapagliflozin exposure 6.58-fold after acute exposure and 2.11-fold after chronic ...
A new narrative review finds that SGLT2 inhibitors and incretin-based therapies preferentially reduce fat while lean tissue loss generally stays ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.